However, one of the key observations of our study was that in patients with severe COVID-19 soluble ACE2 increases to such levels that directly impact on angiotensin 1-7 levels in the circulation reflecting an overall shift to alternative RAS metabolite levels. This evidence concerns the gene ACE2 and COVID-19.